RECENT studies have implicated the thalamus as a possible site for neu
roanatomical and neurochemical changes in schizophrenia. In the presen
t study, we investigated thalamic neurochemical correlates of behavior
s potentially linked to schizophrenia. Whole thalamic DOPAC levels wer
e elevated in rats that had poor extinction of the acoustic startle re
sponse. The dopamine agonist apomorphine microinjected into the ventro
medial thalamus (VmT) disrupted prepulse inhibition of startle. Catale
psy was induced by VmT microinjections of the GABA-A agonist muscimol.
A previous study revealed attentional disturbances and suppression of
frontal cortical metabolic activity after muscimol microinjections in
to the mediodorsal thalamic nucleus. Together with recent findings of
neuron cell loss and elevated DA levels in the thalamus of schizophren
ics, these data suggest the involvement of disturbances of thalamic ne
urotransmission in schizophrenia.